Turoctocog alfa
- Generic Name
- Turoctocog alfa
- Brand Names
- Novoeight, Zonovate, NovoEight
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1192451-26-5
- Unique Ingredient Identifier
- 969NZA3X9T
- Background
Turoctocog alfa is a recombinant factor VIII (rFVIII) with a truncated B-domain made from the sequence coding for 10 amino acids from the N-terminus and 11 amino acids from the C-terminus of the naturally occurring B-domain. Turoctocog alfa is produced in Chinese hamster ovary (CHO) cells without addition of any human- or animal-derived materials. During sec...
- Indication
Turoctocog alfa is indicated for the treatment and prophylaxis of bleedings in patients presenting hemophilia A. The treatment with turoctocog alfa is related with its use to control bleeding episodes or as a perioperative management. Hemophilia A is a hereditary hemorrhagic disorder generated by the congenital deficit of the coagulation factor VIII. This di...
- Associated Conditions
- Bleeding
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.